Cargando…

Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

INTRODUCTION: This study translated and validated the Urdu version of the European Organization for Research and Treatment of Cancer Quality of Life (QoL) Questionnaire (EORTC QLQ-C30) and Brain Module (QLQ-BN20) amongst patients with primary brain tumors (PBT) in Pakistan, and assessed the correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahid, Nida, Martins, Russell Seth, Zahid, Wajeeha, Khalid, Wardah, Azam, Iqbal, Bhamani, Shireen Shehzad, Asad, Nargis, Ahmad, Khabir, Jabbar, Adnan Abdul, Shamim, Muhammad Shahzad, Khan, Rashid Jooma, Javed, Gohar, Bari, Ehsan, Enam, Syed Ather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421474/
https://www.ncbi.nlm.nih.gov/pubmed/34487251
http://dx.doi.org/10.1186/s41687-021-00354-6
_version_ 1783749090314551296
author Zahid, Nida
Martins, Russell Seth
Zahid, Wajeeha
Khalid, Wardah
Azam, Iqbal
Bhamani, Shireen Shehzad
Asad, Nargis
Ahmad, Khabir
Jabbar, Adnan Abdul
Shamim, Muhammad Shahzad
Khan, Rashid Jooma
Javed, Gohar
Bari, Ehsan
Enam, Syed Ather
author_facet Zahid, Nida
Martins, Russell Seth
Zahid, Wajeeha
Khalid, Wardah
Azam, Iqbal
Bhamani, Shireen Shehzad
Asad, Nargis
Ahmad, Khabir
Jabbar, Adnan Abdul
Shamim, Muhammad Shahzad
Khan, Rashid Jooma
Javed, Gohar
Bari, Ehsan
Enam, Syed Ather
author_sort Zahid, Nida
collection PubMed
description INTRODUCTION: This study translated and validated the Urdu version of the European Organization for Research and Treatment of Cancer Quality of Life (QoL) Questionnaire (EORTC QLQ-C30) and Brain Module (QLQ-BN20) amongst patients with primary brain tumors (PBT) in Pakistan, and assessed the correlation of QoL with resilience, depression, and anxiety. METHODS: Translation of the EORTC QLQ-C30 and QLQ-BN20 was performed as per EORTC guidelines. A survey comprising of Urdu translations of EORTC QLQ-C30, QLQ-BN20, Wagnild and Young Resilience Scale (RS-14) and Hospital Anxiety and Depression Scale was administered to patients with PBT at a tertiary care hospital in Pakistan. Reliability (via Cronbach alpha), content validity index (CVI) scores, construct validity, and inter-scale correlations were assessed. RESULTS: Our sample consisted of 250 patients with PBT, most commonly glioma (46.8%) and meningioma (21.2%). All patients were able to understand the Urdu translations. The Cronbach alphas for the QLQ-C30 and the QLQ-BN20 were 0.860 and 0.880, respectively. The CVI scores for clarity and relevance were high for both the EORTC QLQ-C30 (0.98 and 0.96, respectively) and the QLQ-BN20 tool (0.81 and 0.95, respectively). The global QoL domain (EORTC QLQ-C30) showed significant positive correlations with resilience (r = 0.422), and significant negative correlations with depression (r =  − 0.541) and anxiety (r =  − 0.502). Strong inter-scale correlations were observed between physical functioning and insomnia (r =  − 0.690) and role functioning and insomnia (r =  − 0.641). CONCLUSION: Our study confirms the Urdu versions of the EORTC QLQ-C30 and QLQ-BN20 as valid clinical tools for the measurement of QoL in primary brain tumors patients within the cultural and socioeconomic context of Pakistan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00354-6.
format Online
Article
Text
id pubmed-8421474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84214742021-09-22 Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients Zahid, Nida Martins, Russell Seth Zahid, Wajeeha Khalid, Wardah Azam, Iqbal Bhamani, Shireen Shehzad Asad, Nargis Ahmad, Khabir Jabbar, Adnan Abdul Shamim, Muhammad Shahzad Khan, Rashid Jooma Javed, Gohar Bari, Ehsan Enam, Syed Ather J Patient Rep Outcomes Research INTRODUCTION: This study translated and validated the Urdu version of the European Organization for Research and Treatment of Cancer Quality of Life (QoL) Questionnaire (EORTC QLQ-C30) and Brain Module (QLQ-BN20) amongst patients with primary brain tumors (PBT) in Pakistan, and assessed the correlation of QoL with resilience, depression, and anxiety. METHODS: Translation of the EORTC QLQ-C30 and QLQ-BN20 was performed as per EORTC guidelines. A survey comprising of Urdu translations of EORTC QLQ-C30, QLQ-BN20, Wagnild and Young Resilience Scale (RS-14) and Hospital Anxiety and Depression Scale was administered to patients with PBT at a tertiary care hospital in Pakistan. Reliability (via Cronbach alpha), content validity index (CVI) scores, construct validity, and inter-scale correlations were assessed. RESULTS: Our sample consisted of 250 patients with PBT, most commonly glioma (46.8%) and meningioma (21.2%). All patients were able to understand the Urdu translations. The Cronbach alphas for the QLQ-C30 and the QLQ-BN20 were 0.860 and 0.880, respectively. The CVI scores for clarity and relevance were high for both the EORTC QLQ-C30 (0.98 and 0.96, respectively) and the QLQ-BN20 tool (0.81 and 0.95, respectively). The global QoL domain (EORTC QLQ-C30) showed significant positive correlations with resilience (r = 0.422), and significant negative correlations with depression (r =  − 0.541) and anxiety (r =  − 0.502). Strong inter-scale correlations were observed between physical functioning and insomnia (r =  − 0.690) and role functioning and insomnia (r =  − 0.641). CONCLUSION: Our study confirms the Urdu versions of the EORTC QLQ-C30 and QLQ-BN20 as valid clinical tools for the measurement of QoL in primary brain tumors patients within the cultural and socioeconomic context of Pakistan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00354-6. Springer International Publishing 2021-09-06 /pmc/articles/PMC8421474/ /pubmed/34487251 http://dx.doi.org/10.1186/s41687-021-00354-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Zahid, Nida
Martins, Russell Seth
Zahid, Wajeeha
Khalid, Wardah
Azam, Iqbal
Bhamani, Shireen Shehzad
Asad, Nargis
Ahmad, Khabir
Jabbar, Adnan Abdul
Shamim, Muhammad Shahzad
Khan, Rashid Jooma
Javed, Gohar
Bari, Ehsan
Enam, Syed Ather
Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title_full Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title_fullStr Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title_full_unstemmed Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title_short Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients
title_sort translation and validation of the urdu version of the european organization for research and treatment of cancer core quality of life questionnaire (eortc qlq-c30) and brain module (qlq-bn20) in primary brain tumor patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421474/
https://www.ncbi.nlm.nih.gov/pubmed/34487251
http://dx.doi.org/10.1186/s41687-021-00354-6
work_keys_str_mv AT zahidnida translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT martinsrussellseth translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT zahidwajeeha translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT khalidwardah translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT azamiqbal translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT bhamanishireenshehzad translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT asadnargis translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT ahmadkhabir translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT jabbaradnanabdul translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT shamimmuhammadshahzad translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT khanrashidjooma translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT javedgohar translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT bariehsan translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients
AT enamsyedather translationandvalidationoftheurduversionoftheeuropeanorganizationforresearchandtreatmentofcancercorequalityoflifequestionnaireeortcqlqc30andbrainmoduleqlqbn20inprimarybraintumorpatients